Page 841«..1020..840841842843..850860..»

Election 2020: The contest in the 11th Senatorial District – The Mercury

Posted: November 5, 2020 at 12:59 pm

The race to represent the 11th Senatorial District in Harrisburg pits a Democratic incumbent against a Republican challenger.

The district includesReading, Birdsboro, Centerport, Fleetwood, Kenhorst, Kutztown, Laureldale, Leesport, Lyons, Mohnton, Mount Penn, New Morgan, Shillington, St. Lawrence, Topton, West Reading and Wyomissing; and Alsace, Bern, Brecknock, Caernarvon, Centre, Cumru, Exeter, Lower Alsace, Maxatawny, Muhlenberg, Oley, Richmond, Robeson and Ruscombmanor townships.

State senators serve a four-year term and receive an annual salary of $90,300.

We asked the candidates to respond to this question:

Question: The impact of the coronavirus pandemic has been widespread and severe, affecting everything from the economy to health care to education. As the state fights to recover from this global health crisis, what specific steps do you feel need to be taken to aid that recovery?

Background: Incumbent, previously served as dean of agricultural and environmental science at Delaware Valley College, former Berks County commissioner for eight years, former chief executive of 10,000 Friends of Pennsylvania.

Answer: The pandemic has presented us with unprecedented challenges that we must still overcome, but I believe that it also provides us with an opportunity to reimagine the way we deliver government services to build a brighter future for all Pennsylvanians.

In the short term, as we take prudent steps to reopen our economy and achieve a new sense of normality, we must continue to provide the unemployed a financial lifeline until jobs reopen for them, offer businesses especially small businesses the resources they need to recover, and tackle the tough task of completing the 2020-2021 state budget to meet the needs of our citizens within the revenues available.

Long term, making health care, including preventative medicine, more accessible possibly via technology like telemedicine; increasing access to high-quality, affordable child care; offering more educational opportunities across our lifespans, promoting lifelong learning and attainment; developing a more equitable way to pay for education that has school property tax elimination in mind; improving our road, water, sewer and technology (particularly broadband) infrastructure; working to mitigate the impacts of climate change with renewable energy and regenerative agriculture and, making government a better partner with business will help us achieve prosperity beyond COVID.

Annette Baker

Background: Homemaker and home-school teacher, local radio personality, chairwoman of the Berks County Republican Committees southern region and former environmental scientist.

Website: annettecbakerforsenate.wordpress.com

Answer: The citizens of our commonwealth have suffered greatly because of the pandemic and we will be feeling the effects of COVID-19 for many years to come. No sector of our economy has been left untouched.

Rebuilding must begin with helping small businesses and restaurants. Many of them are on the verge of closing permanently. They must be able to reopen at full capacity. Educational institutions must also open, supporting parents returning to full employment.

Employers and employees, while following guidelines, are capable of solving the problems facing the reopening of our state. When the government gets out of the way, people can find solutions to difficult problems. By getting people back to work, we will begin to provide stability to families and businesses in the commonwealth. This is important not only for our economic well-being but for the physical and mental well-being of our residents.

I will support legislation such as House Bill 836 because it is time to reopen our economy. The governor and General Assembly should be working together to determine whether emergency declarations should be extended. It is time to unite together to move forward and restore normalcy to our commonwealth.

Here is the original post:
Election 2020: The contest in the 11th Senatorial District - The Mercury

Posted in Preventative Medicine | Comments Off on Election 2020: The contest in the 11th Senatorial District – The Mercury

‘Escape from the pandemic era’ – expert report makes case for prevention, for human and planetary health – Croakey

Posted: November 5, 2020 at 12:59 pm

Introduction by Croakey: A CSIRO report released on Wednesday warns Australia is at risk of increased disease outbreaks and pest incursions, weakened exports, and damage to its global trading reputation.

It says:

In the five years to 2017, the amount of biosecurity risk materials intercepted in Australia increased by almost 50 per cent. At the same time, the risk of biosecurity threats like pandemics are on the rise, fuelled by global trade and travel, urbanisation, climate change, biodiversity loss and antimicrobial resistance.

The report Australias Biosecurity Future: Unlocking the next decade of resilience was co-developed with Animal Health Australia, Plant Health Australia and the Centre for Invasive Species Solutions.

CSIROs Director of Health and Biosecurity Dr Rob Grenfell said in a statement COVID-19 illustrated the interconnectedness between human, animal and environmental health and where a weakness in one is a vulnerability for all.

How Australia navigates the changes needed over the next decade will significantly impact the health of Australians, our communities, ecosystems and agricultural systems and food security into the future, he said.

The CSIRO report follows the release of a new global report into biodiversity and pandemics, published by the high-level Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES).

As Croakey journalist Amy Coopes reports below, it says the underlying drivers of pandemics are the same global environmental changes that drive biodiversity loss and climate change.

It warns that unless there is a seismic shift in how countries collectively deal with infectious diseases, future pandemics will emerge more often, spread more rapidly, cause greater damage to the global economy and kill more people than COVID-19,

Pandemics, climate change and biodiversity loss all share common drivers, and without transformative action novel infectious diseases outbreaks will emerge more often, spread more rapidly, kill more people, and affect the global economy with more devastating impact than ever before.

This is the stark warning offered by a new report into biodiversity and pandemics, published by the high-level Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES).

The report, which IPBES describes as one of the most scientifically robust examinations of the evidence and knowledge about pandemic risk and nature since the COVID-19 pandemic began, cites more than 700 sources from across the fields of epidemiology, zoology, public health, disease ecology, comparative pathology, veterinary medicine, pharmacology, wildlife health, mathematical modelling, economics, law and public policy.

It offers a frank assessment of emerging infectious diseases, outbreaks of which is says are becoming more frequent, entirely driven by human activities.

The IPBES report describes the underlying drivers of pandemics as the same global environmental changes that drive biodiversity loss and climate change, including land use changes, agricultural expansion and intensification, and wildlife trade and consumption:

These drivers of change bring wildlife, livestock, and people into closer contact, allowing animal microbes to move into people and lead to infections, sometimes outbreaks, and more rarely into true pandemics that spread through road networks, urban centers and global travel and trade routes.

The recent exponential rise in consumption and trade, driven by demand in developed countries and emerging economies, as well as by demographic pressure, has led to a series of emerging diseases that originate mainly in biodiverse developing countries, driven by global consumption patterns.

Pandemics such as COVID-19 underscore both the interconnectedness of the world community and the rising threat posed by global inequality to the health, wellbeing and security of all people.

Current pandemic strategies focused on disease response but, as the novel coronavirus pandemic had shown, this was a slow and uncertain path that resulted in mounting human costs: in lives lost, sickness endured, economic collapse, and lost livelihoods, the report said

Instead, it advocated for preventative strategies focused on the reduction of anthropogenic global environmental change.

Pandemic risk could be significantly lowered by promoting responsible consumption and reducing unsustainable consumption of commodities from emerging disease hotspots, and of wildlife and wildlife-derived products, as well as by reducing excessive consumption of meat from livestock production. it said.

Conservation of protected areas, and measures that reduce unsustainable exploitation of high biodiversity regions will reduce the wildlife-livestock-human contact interface and help prevent the spillover of novel pathogens.

Without action to tackle the common drivers of climate change, biodiversity loss and emerging infectious disease, the report said pandemics would emerge more often, spread more rapidly, kill more people, and affect the global economy with more devastating impact than ever before.

It said the risk of pandemics was already rapidly increasing, with 1.7 million undiscovered viruses thought to exist in avian and mammal hosts, of which up to 850,000 could have the ability to infect humans a so-called spillover or zoonotic event which accounted for the majority (70 percent) of emerging infectious disease (Ebola, Nipah, Zika) and almost all known pandemics (HIV/AIDS, influenza, COVID-19).

It estimated that more than a third of new diseases seen in the past 60 years had been caused by land use changes including deforestation, human settlement, urbanisation, and expansion of crop and livestock production. These created synergistic effects with climate change that had, in concert with biodiversity loss, seen the emergence of important novel pathogens, the report said.

More than five new diseases emerged in humans every year with the potential to spread, driven by exponentially increasing anthropogenic changes, it said, estimating the annual cost of such emerging pathogens as likely in excess of $1 trillion.

Climate change has been implicated in disease emergence and will likely cause substantial future pandemic risk by driving movement of people, wildlife, reservoirs, and vectors, and spread of their pathogens, in ways that lead to new contact among species, increased contact among species, or otherwise disrupts natural host-pathogen dynamics, it said.

On an economic basis alone, the report said pandemic prevention made more sense than reflexive response, with risk reduction and surveillance costing two orders of magnitude less than the damage wrought by a global outbreak.

Though it said the true cost of COVID-19 would not be known until vaccines had been fully deployed and transmission contained, the bill had been put at $16 trillion in the US alone by the fourth quarter of 2021 (and that assumed an effective vaccine). Risk reduction would cost 100 times less, it said.

Looking ahead, it said land use decisions largely failed to account for human health, and health should be a key consideration for ecological restoration, which it described as critical for conservation, climate adaptation and provision of ecosystem services.

The report highlighted the importance of equity considerations, noting that pandemics affected countries and populations unequally, with the elderly and minorities suffering disproportionate impacts from COVID-19.

It said both disease and economic outcomes were often more severe on women, people in poverty and Indigenous peoples, and to be transformative, pandemic control policies and recovery programs should be more gender responsive and inclusive.

The report makes a number of recommendations on pandemic prevention, including, crucially, designing a green economic recovery from COVID-19 as an insurance against future outbreaks. It also calls for:

The report says its recommendations come at a critical juncture in the course of the COVID-19 pandemic and the Great Acceleration of the Anthropocene, where the manifest inadequacy of current reactive approaches have been underscored by more than one million human deaths and a huge socioeconomic toll.

Dr Peter Daszak chaired the expert workshop which authored the report, and he said there was no great mystery about the cause of the COVID-19 pandemic or of any modern pandemic.

The same human activities that drive climate change and biodiversity loss also drive pandemic risk through their impacts on our environment, said Daszak.

Changes in the way we use land; the expansion and intensification of agriculture; and unsustainable trade, production and consumption disrupt nature and increase contact between wildlife, livestock, pathogens and people. This is the path to pandemics.

He concluded:

We have the increasing ability to prevent pandemics but the way we are tackling them right now largely ignores that ability. Our approach has effectively stagnated we still rely on attempts to contain and control diseases afterthey emerge, through vaccines and therapeutics.

We can escape the era of pandemics, but this requires a much greater focus on prevention in addition to reaction.

The fact that human activity has been able to so fundamentally change our natural environment need not always be a negative outcome. It also provides convincing proof of our power to drive the change needed to reduce the risk of future pandemics while simultaneously benefiting conservation and reducing climate change.

See the original post:
'Escape from the pandemic era' - expert report makes case for prevention, for human and planetary health - Croakey

Posted in Preventative Medicine | Comments Off on ‘Escape from the pandemic era’ – expert report makes case for prevention, for human and planetary health – Croakey

Global Medical Wellness Market Import Export Scenario, Application, Growing Trends and Forecast 2020-2025 – The Think Curiouser

Posted: November 5, 2020 at 12:59 pm

MarketQuest.biz has recently announced a new report entitled Global Medical Wellness Market 2020 by Company, Type and Application, Forecast to 2025 offers an overview of the market by giving market data with characteristics and market chain with analysis and developments and increase. The report delivers a comprehensive analysis of the global market which presents the critical analysis of the current state of the global Medical Wellness industry, demand for the product, environment for investment, and existing competition. Point by point data about the market players who are holding a fundamental position in the market concerning the business, revenue, open market development, and the temporary courses of action are listed in the market. It covers segments such as competitor segment, product type segment, end use/application segment, and geography segment.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Key Players Profiles:

The report provides present competitive analysis as well as valuable insights to industries or other clients to help them penetrate in a global market. Businesses will get a competitive advantage from this competitive research analysis. The report then covers gives a detailed overview of global Medical Wellness industry prime vendors and regional evaluation with forecast period 2020 to 2025. The research focuses on primary and secondary drivers, market share, leading segments, and regional analysis. It also delivers the market competitive landscape and an elementary inspection of the regional growth of the market.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/17182

Developments and future opportunities estimated to emerge in the global Medical Wellness industry are looked into in this portion of the study. The report also throws light on the competitive landscape, underlining the corporate strategies that the prominent players across various geographies have employed to get ahead in this industry. The research focuses on business consulting, industry chain research, and consumer research to help customers provide non-linear revenue models within this market.

Geographically, this report is segmented into several key regions including North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa). Moreover, the market potential for each geographical region with respect to the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios is analyzed in this report.

This research report also includes profiles of major companies operating in the global market. Some of the prominent players operating in the global Medical Wellness market are: Massage Envy, Nanjing Zhaohui, Fitness World, Steiner Leisure Limited, VLCC Wellness Center, World Gym, HEALING HOTELS OF THE WORLD, Beauty Farm, Universal Companies, Edge Systems LLC, Kayco Vivid, WTS International, Golds Gym International, Guardian Lifecare, Arashiyu Japanese Foot Spa, The Body Holiday, Bon Vital, Biologique Recherche, Enrich Hair & Skin, Kaya Skin Clinic, Healthkart

Based on type, the market has been segmented into: Complementary and Alternative Medicine, Beauty Care and Anti-Aging, Preventative & Personalized Medicine and Public Health, Healthy Eating, Nutrition & Weight Loss, Rejuvenation, Other

Based on application, the market has been segmented into: Franchise, Company Owned Outlets

ACCESS FULL REPORT: https://www.marketquest.biz/report/17182/global-medical-wellness-market-2020-by-company-type-and-application-forecast-to-2025

Key Features of The Global Market Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

MarketQuest.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. MarketQuest.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. MarketQuest.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketquest.biz

Read more from the original source:
Global Medical Wellness Market Import Export Scenario, Application, Growing Trends and Forecast 2020-2025 - The Think Curiouser

Posted in Preventative Medicine | Comments Off on Global Medical Wellness Market Import Export Scenario, Application, Growing Trends and Forecast 2020-2025 – The Think Curiouser

More Virginia Seniors Are Dying From Dementia. Social Isolation Might Be the Cause. – The Dogwood

Posted: November 5, 2020 at 12:59 pm

CHARLOTTESVILLE- When you talk about COVID-19, most of the conversation involves the actual virus. You talk about symptoms or how long quarantine lasts. But the pandemic also brought less physical problems, issues that arent being addressed.

Dementia-related deaths surged over the last seven months in Virginia. Over the summer, 61,000 people died from dementia in Virginia, 11,000 more than 2019, according to the Centers for Disease Control and Prevention. And while experts arent 100% positive of the cause, many speculate that its due to the pandemic. Not as a symptom of the actual virus, but a tragic side effect of the new social norms.

While the numbers are staggering, it does not reflect nearly the amount of people with COVID infections, said Dr. Laurie Archbald-Pannone, who specializes in geriatric medicine at the University of Virginia. Rather its shows the effect that the COVID era has on the care of people with dementia.

According to Archbald-Pannone, some of the necessary rules to control the viruses spread have negatively effected older people with dementia and their caregivers. After caring for dementia patients for over twenty years, the CDCs statistic didnt surprise her. Shes witnessed the effects of the pandemics isolation on their lives firsthand.

As we enter the first year of the pandemic, its important that we find creative ways to stay connected in our communities, said Archbald-Pannone. We need to support each other through the challenges that were going through.

People misunderstand a lot of things about dementia. Usually when we hear the term, we tend to think of a pretty singular picture. But theres no one way to have dementia. Its a disease that exists on a wide spectrum, one that can affect people in different ways. However, social isolation is pretty harmful to most forms of the illness.

Now, to be clear, there is a difference between social distancing and social isolation. The problem is that people right now tend to confuse the two.

Social distancing is a part of the overall infection prevention methods to decrease the spread of the virus, she said. Social isolation, however, not a good thing. Its when were disconnected from our community. Being socially engaged while being socially distant is a part of figuring out how to survive in the COVID era.

Social isolation can have distarous effects on our bodies. According to UVA Health, socially isolated people have higher rates of dementia as well as heart disease, high blood pressure, depression, cognitive decline and death. To Archbald-Pannone, its no coincidence that this increase has happened alongside the COVID-19 pandemic.

Humans are social creatures. We need social interaction for not only our physical health, but our mental health as well. Dementia causes memory loss, typically effecting people 65 years of age or older. Social connections, like talking on the phone, is especially helpful for people living with the condition.

Caring for someone living with dementia can be a very difficult job, especially if theyre a loved one. In the most severe cases, a caregiver may be dressing, bathing, and even feeding a patient, often 24 hours a day. This doesnt even take into account the emotional toll that this has on a person. Watching the decline of a family member, spouse or a friend is tremendously difficult.

Even on the good days, caring for someone with dementia can be taxing, said Archbald-Pannone. Caring for someone close to us can be hard. Unrecognized burdens can fall on the caregiver. And this was before COVID.

Nowadays, these caregivers are just as isolated as their patients, creating a much higher risk of them burning out.

For dementia patients to get the best care, their caregivers also need care and support, said Archbald-Pannone. If caregivers are not in good shape physically or mentally, people living with dementia may not receive the best care possible.

We have to make sure that healthcare providers are becoming aware of this and are actively reaching out to caregivers whether theyre at home or in facilities, said Archbald-Pannone. We have to ask how we can support them and how can we alleviate any additional stressors that have been brought on by COVID.

Throughout the summer, no one wanted to go to their doctor for a checkup. Even if it was a serious health issue, there was and still is a fear that if you go to a hospital, you could potentially leave with COVID-19. However, if you have a chronic condition like dementia, consistent treatment is non-negotiable.

In the spring and the summer, we saw that people had less access to their primary care physicians for preventative care, said Archbald-Pannone. And its really important that were keeping up with their chronic medical conditions and giving them what they need when they need it.

Increased access to medical care was a must. But, in the COVID era, healthcare professionals have to provide for their patients in a whole new way. the solution was telemedicine. Telemedicine has made it possible for doctors to see their patients remotely. Holding doctors visits over the phone or through video chat is a safer alternative to an in-person visit. So this way, they can meet their patients medical needs while making sure no one gets exposed to COVID-19.

However, Archbald-Pannone raised a good point. Telemedicine may not always be a viable option for those with dementia. Doctors and long-term care providers must take extra steps.

Telemedicine, often an option for other patients, may not be manageable for those with dementia, she said. Physicians and staff need to reach out to them. But, on a positive note, this may allow long-distance loved ones a chance to help with their relatives medical care.

In our geriatric clinic, we have the option of getting routine visits done via video interface or over the phone. And this even carries additional benefits, like, if someones loved one lives out of state or isnt able to come to an in-person visit, theyre able to join remotely through telemedicine visits, said Archbald-Pannone.

If someone you know has dementia, Archbald-Pannone says that checking in on them is the best thing to do. However, she wants to make it clear that this does not mean throw caution into the wind. Maintaining CDC-reccomended guidelines is still of the utmost importance. Now, people just need to get more creative with communication skills.

It can be as simple as a phone call. It may not be the safest option to connect physically with people. But calling them on the phone to check in can be helpful, said Archbald-Pannone. We dont always need to have the answers. Sometimes being a listening ear can be enough.

If you think a loved one may be suffering from dementia, the best thing to do is talk to a medical professional. There are many early, warning signs of dementia. But, with the elderly, that can be tough. Its hard to distinguish between which signs are normal facets of aging and which ones are symptoms. Talking to a professional is the best way to know for sure. If you or a loved one needs help with dementia, you can call this 24/7 hotline, 800.272.3900, or visit the Alzheimers Associationswebsite.

Arianna Coghill is a content producer at the Dogwood. You can reach her at arianna@couriernewsroom.com

Continued here:
More Virginia Seniors Are Dying From Dementia. Social Isolation Might Be the Cause. - The Dogwood

Posted in Preventative Medicine | Comments Off on More Virginia Seniors Are Dying From Dementia. Social Isolation Might Be the Cause. – The Dogwood

A Review of Stem CellBased Therapies for Parkinson Disease – AJMC.com Managed Markets Network

Posted: November 5, 2020 at 12:58 pm

Researchers discuss the development and potential of stem cellbased therapies in the treatment of Parkinson disease.

In assessing treatment for Parkinson disease (PD), the current standard of care involves levodopa, potentially in combination with carbidopa, to address the loss of dopamine known to occur as the condition progresses. However, several innovations in therapy for PD have occurred in recent years, particularly deep brain stimulation and the potential use of stem cells.

Discussing in a review published in International Journal of Molecular Sciences, researchers Zhaohui Liu, PhD, MSc, and Hoi-Hung Cheung, PhD, sought to discuss the development of new therapeutic strategies that have led to the initiation of exploratory clinical trials, particularly the application of stem cells for the treatment of PD.

Delving into the use of stem cellbased treatments in PD, the researchers say that several important pathways have emerged as targets for potential therapeutic intervention.

Conventional therapeutic strategies for relieving the symptomatic stages of PD remain, but with new genetic insights, it may be possible to use preventive neuroprotective treatments for people at risk of developing PD, they highlight. In parallel with efforts to prevent and control symptomatic PD, researchers are also investigating stem cells as replacements for diseased neurons or degenerated tissues.

As they note, dopaminergic (DA) cell transplantation is believed to be the most promising cell replacement therapy. Aligned with this approach, a recent novel treatment showcased the plausibility of reprogramming the skin cells of a single patient with PD to take on the characteristics of DA neurons and replace damaged brain cells. In their findings, the patient exhibited improvements in quality of life and day-to-day activities requiring motor skills. However, as this treatment was performed on only 1 person, the researchers cautioned that larger, diverse clinical studies are needed to demonstrate further efficacy and long-term results.

Other notable stem cellbased treatments include:

Although we are not yet examining a disease-modifying treatment, stem cell transplantation has the potential to be at the forefront of such PD treatments in the future, conclude the researchers. The transplantation process and the procedures required for its optimization are still not fully understood, and further research is required to achieve treatment for PD.

Reference

Liu Z, Cheung H-H. Stem cell-based therapies for Parkinson disease. Int J Mol Sci. Published online October 29, 2020. doi:10.3390/ijms21218060

Read the original post:
A Review of Stem CellBased Therapies for Parkinson Disease - AJMC.com Managed Markets Network

Posted in Stem Cells | Comments Off on A Review of Stem CellBased Therapies for Parkinson Disease – AJMC.com Managed Markets Network

Stem cells key to ALS therapy – Agoura Hills Acorn

Posted: November 5, 2020 at 12:58 pm

By The Acorn Staff | on November 05, 2020

Twenty years ago, when stem cell therapy was highly regulated in the United States and other countries, it was well underway in the Hadassah Hospital labs in Jerusalem.

Never would we have imagined that the U.S. expansion of one of the key clinical trials conducted in our labs in Israel would be later funded by Californias Stem Cell Institute.

In 2004, California had the foresight to advance this critical area of research with the passage of Prop. 71 in 2004.

Stem cells replace damaged or diseased tissue. In this way, treatments or cures for diseases like age-related macular degeneration, ALS, MS, Parkinsons, Alzheimers and diabetes could be a reality in the foreseeable future.

I come to this subject from a place of personal sorrow. I watched my father-in-law, Irv, suffer for 12 years with ALS, a man I loved as if he were my own father. He fought hard. He made every minute of his battle meaningful, to soak up as much life as he could until he couldnt.

Hadassah researchers conducted the worlds first clinical trial using the patients own bone marrow stem cells to treat ALS. Expanded stem cell trials are now taking place here in California to treat ALS.

The California Stem Cell Agencys ALS funding has awarded a total of $79 million in grants to understand ALS and then to translate those discoveries into treatments and therapies. Two have already reached the clinical trial phase.

A Phase 1 clinical trial at Cedars-Sinai was funded to investigate the safety and efficacy of ways in which surviving neurons can be protected in people with ALS.

The second, a Phase 3 clinical trial at Brainstorm Cell Therapeutics, first began in Israel. The approach is to use mesenchymal stem cells derived from bone marrow boosted with protective factors to support and protect the neurons of ALS patients.

Stacey DorenfeldAgoura Hills

Dorenfeld is the National State Advocacy co-chair and the Hadassah Southern California advocacy chair.

Go here to read the rest:
Stem cells key to ALS therapy - Agoura Hills Acorn

Posted in Stem Cells | Comments Off on Stem cells key to ALS therapy – Agoura Hills Acorn

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q…

Posted: November 5, 2020 at 12:58 pm

This article was originally published here

Stem Cell Res. 2020 Oct 15;49:102030. doi: 10.1016/j.scr.2020.102030. Online ahead of print.

ABSTRACT

Multiple myeloma (MM) is a hematological cancer characterized by an uncontrolled proliferation of antibody-secreting plasma cells within the bone marrow. Currently, cell therapy such as chimeric antigen receptor T-cell (CAR-T) based on induced pluripotent stem cells (iPSCs) has received attention for treating MM. However, the generation of iPSCs from MM patients appears to be very rarely reported. Here we generated an iPSC line from CD34+ bone marrow cells of a patient with MM using human placenta-derived cell conditioned medium (hPCCM), offering a relatively high efficiency in humanized conditions. This iPSC line might be a useful model for research on MM.

PMID:33142253 | DOI:10.1016/j.scr.2020.102030

See more here:
Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q...

Posted in Stem Cells | Comments Off on Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q…

Human Embryonic Stem Cells (HESC) Market 2020 Manufacturer Analysis, Emerging Trends, Top Companies and Forecast to 2027 – TechnoWeekly

Posted: November 5, 2020 at 12:58 pm

Human Embryonic Stem Cells (HESC) Market Size And Forecast

A comprehensive overview of the Human Embryonic Stem Cells (HESC) Market is recently added by Market Research Intellect to its humongous database. Furthermore, the Human Embryonic Stem Cells (HESC) Market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, this innovative report makes use of SWOT, PESTLE, and Porters Five Forces analyses to get a closer outlook on the Human Embryonic Stem Cells (HESC) Market. Furthermore, the Human Embryonic Stem Cells (HESC) Market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Human Embryonic Stem Cells (HESC) Market at the global and regional levels. The study covers the impact of various drivers and manacles on the Human Embryonic Stem Cells (HESC) Market growth opportunities over the forecast period.

Impact of Covid-19 :

During the first quarter of 2020, different global economies were badly impacted by a viral outbreak of COVID-19. This viral outbreak of the Covid-19 was later recognized as a global pandemic by the World Health Organization (WHO). COVID-19 spread in different global countries, affecting a large number of people in a short timeframe. The outburst of COVID-19 adversely hit different global economies in the world. The stringent regulations imposed by several governments, including complete lockdown and quarantine methodologies to fight against COVID-19, resulted in a massive impact on various business sectors. We at Market Research Intellect offer an informative report on the Human Embryonic Stem Cells (HESC) Market which helps in making strategic decisions over the forecast period.

Competitive Landscape:

The degree of competition among leading global companies has been elaborated by examining various leading key players operating across the global regions An expert team of research analysts sheds light on various attributes such as -global market competition, market share, latest industry developments, innovative product launches, partnerships, mergers or acquisitions by leading companies in the Human Embryonic Stem Cells (HESC) Market. The leading manufacturers have been analyzed by using research methodologies for getting insight views on global competition.

Following key players have been profiled with the help of proven research methodologies:

The Human Embryonic Stem Cells (HESC) Market has been examined into different global market segments such as type, applications and global geographies. Each and every global market segment has been studied to get informative insights into various global regions.

Human Embryonic Stem Cells (HESC) Market Segmentation:

Human Embryonic Stem Cells (HESC) Market Segment by Type:

Human Embryonic Stem Cells (HESC) Market Segment by Application:

Human Embryonic Stem Cells (HESC) Market Segment by Global Presence:

North America Latin America Middle East Asia-Pacific Africa Europe

The report has been aggregated by using a couple of research methodologies such as primary and secondary research techniques. It helps in collecting informative pieces of professional information for deriving effective insights into the market. This informative report helps in making well informed and strategic decisions throughout the forecast period.

Key questions answered through this analytical market research report include:

What are the latest trends, new patterns and technological advancements in the Human Embryonic Stem Cells (HESC) Market? Which factors are influencing the Human Embryonic Stem Cells (HESC) Market over the forecast period? What are the global challenges, threats and risks in the Human Embryonic Stem Cells (HESC) Market? Which factors are propelling and restraining the Human Embryonic Stem Cells (HESC) Market? What are the demanding global regions of the Human Embryonic Stem Cells (HESC) Market? What will be the global market size over the coming future? What are the different effective business strategies followed by global companies?

If you have any custom requirements, please let us know and we will offer you the customized report as per your requirements.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Website https://www.marketresearchintellect.com/

Go here to see the original:
Human Embryonic Stem Cells (HESC) Market 2020 Manufacturer Analysis, Emerging Trends, Top Companies and Forecast to 2027 - TechnoWeekly

Posted in Stem Cells | Comments Off on Human Embryonic Stem Cells (HESC) Market 2020 Manufacturer Analysis, Emerging Trends, Top Companies and Forecast to 2027 – TechnoWeekly

Panelists debate the implications and ethics of stem cell research – Johns Hopkins News-Letter

Posted: November 5, 2020 at 12:58 pm

The Alexander Grass Humanities Institute (AGHI), in conjunction with Great Talk, Inc., hosted a panel of scientists to speak about the ethical considerations and implications of stem cell research on Oct. 21.

The event was moderated by Director of AGHI William Egginton. The four panelists included two experts in genomics research, a journalist who specializes in the role of technology in biomedical research and an expert in medical law.

Dr. Anthony Wynshaw-Boris, chair of the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine, discussed how cell lines were cultivated as tools in the past for scientists to use to grow cell cultures to study diseases or develop vaccines. However, there wasnt as much debate about the development of these tools in the past as there is now.

These are scientific tools that we use. The political and social aspects... are arising today because of our polarization, Wynshaw-Boris said.

The panel had an in-depth conversation regarding the ethics of the use of scientific tools such as stem cell lines derived from fetal tissue, embryonic cells, abortion-derived cell lines and cells acquired without consent.

Dr. Eric Green, director of the National Human Genome Research Institute at the National Institutes of Health, argued that the investment that has been made in these cell lines to calibrate them for use in biomedical research cannot be ignored.

Should there be a halt on the use of that mature tool because of its origins that were created in a time when there was a different view? Green asked.

Antonio Regalado, senior editor for biomedicine at MIT Technology Review who writes about the impact of technology on medicine and biomedical research, responded to Greens query.

Regalado brought up the fact that makeup companies have been facing a lot of backlash recently for testing their products on animals. Regalado pointed out that makeup companies could then use a similar argument by saying that since they have already invested money in animal testing procedures, they should not have to find new, less harmful methods of testing.

I don't know that we should rule out the possibility of alternatives if the scientific community decides to put their minds to it. Perhaps an equivalent cell line could be developed, Regalado said.

Diane Hoffman, director of the Law and Health Care Program at the University of Maryland Francis King Carey School of Law, described various perspectives in debate over the ethical concerns of stem cell research.

The challenge, according to Hoffman, is striking a balance between implementing a blanket policy through the government and informing consumers to allow them to make ethical decisions.

Industry wanting innovation, and government wanting safety and efficacy, and consumers wanting access. Those three things are... how we consider these ethical issues, Hoffmann said.

The conversation then shifted to eugenics, the practice of editing human DNA to achieve specific, desirable characteristics, such as eliminating diseases, changing eye color or editing IQ.

Green described an initiative funded by the Human Genome Project, the Ethical, Legal and Social Implications Research Program (ELSI), which focuses on the ethical, legal and social implications of biomedical research.

We can meld together what is scientifically possible to what is the body of evidence of what has come out when we have looked at these ELSI issues and then have conversations... and try to come to consensus on what the guardrails should look like, Green said.

Hoffmann echoed Green, describing the need of the scientific community to also consider allocation of these resources.

Weve got a ways to go in terms of thinking about... how we can be more just in our allocation of medical resources and the benefits of the research were doing, Hoffmann said.

She brought up the idea of giving priority in receiving benefits to vulnerable populations that have been previously harmed by the health-care system.

Wynshaw-Boris added that each study that is conducted needs to address the ELSI considerations mentioned by Green.

Studies have to be done... in partnership with diverse populations, and we have to be committed to that, Wynshaw-Boris said. We have to make progress on it all the time, and that's what we have to be committed to.

The discussion concluded with a consensus among the panelists that the scientific community needs to address social and health inequities as advancements in genetics and genomic techniques continue to occur.

We have to bring more trust to science than exists now, Green said.

The rest is here:
Panelists debate the implications and ethics of stem cell research - Johns Hopkins News-Letter

Posted in Stem Cells | Comments Off on Panelists debate the implications and ethics of stem cell research – Johns Hopkins News-Letter

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview With Detailed Analysis, Competitive Landscape, Emerging Trends ,…

Posted: November 5, 2020 at 12:58 pm

The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market study describes the current market size and market forecast, market prospects, main drivers and constraints, regulatory scenario, industry trend, PESTLE analysis, PORTER analysis, new product approvals / launch, promotion and marketing campaigns, pricing analysis , competitive environment to assist companies in decision-making. The data from the study is focused on current and historical market dynamics that assist in decisions related to investment.

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) offers fundamental industry overview representing market trends, company profiles, growth drivers, market scope and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) size estimation. The valuable Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry insights, type, application, deployment status and research regions are studied. A thorough analysis of gross margin view, trade news, industry plans and policies, constraints are explained. A complete Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry scenario is explained from 2014 to 2019 and forecast estimates are presented from 2020-2029. The productions, industry chain analysis, gross margin structure and deployment models are stated in detail. Top regions analysed in the report include North America, South America, Europe, Asia-Pacific, Middle East & Africa and the rest of the world. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry presence and maturity analysis will lead to investment feasibility and development scope.

Get A Free Sample Copy Here:

https://www.globalmarketers.biz/report/life-sciences/2014-2029-report-on-global-circulating-tumor-cells-(ctcs)-and-cancer-stem-cells-(cscs)-market-by-player,-region,-type,-application-and-sales-channel/152503#request_sample

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Leading Players (2019-2029):

JanssenQiagenAdvanced Cell DiagnosticsApoCellBiofluidicaClearbridge BiomedicsCytoTrackCelseeFluxionGilupiCynvenioOn-chipYZY BioBioViewFluidigmIkonisysAdnaGenIVDiagnosticsMiltenyi BiotecScreenCellSilicon Biosystems

Market Segment Analysis

By Types:

CellSearchOthers

By Applications:

Breast Cancer Diagnosis and TreatmentProstate Cancer Diagnosis and TreatmentColorectal Cancer Diagnosis and TreatmentLung Cancer Diagnosis and TreatmentOther Cancers Diagnosis and Treatment

By Region

North America

Europe

Asia-Pacific

LAMEA

Ask for Discount @:

https://www.globalmarketers.biz/discount_inquiry/discount/152503

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Report addresses different regions like North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. The production value, gross margin analysis, development trend, and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market positioning is explained. The industrial chain study, potential buyers, distributors and traders details are explained. The challenges to the growth and market restraints are explained. The market maturity study, investment scope and gross margin study are profiled. The production process structure, market share, manufacturing cost and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) saturation analysis is covered. This will helps the industry aspirants to analysis growth feasibility and development plans.

A special highlight on cost structure, import-export scenario and sales channels of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry is presented. The benchmarking products, dynamic market changes, upstream raw material and downstream buyers analysis are presented. The business trends, key players analysis and product segment study are explained. The regional SWOT analysis, gross margin analysis, application analysis and industry barriers are explained. The value, volume and consumption from 2019-2024 is portrayed. All the essential details like pricing structure of raw materials, labour cost, sales channels and downstream buyers are presented.

Inquire Before Buying Or Ask For Custom Requirement:

https://www.globalmarketers.biz/report/life-sciences/2014-2029-report-on-global-circulating-tumor-cells-(ctcs)-and-cancer-stem-cells-(cscs)-market-by-player,-region,-type,-application-and-sales-channel/152503#inquiry_before_buying

In the next segment, the forecast Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry perspective is covered. Under forecast statistics, the market value, volume and consumption forecast from 2019-2024 is explained. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) regional analysis for major regions and countries in this region is stated. The study of new Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry aspirants and analysts opinions for this industry is presented. The limitations to the industry growth, market risks, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) growth opportunities and market trends are viewed. The revenue, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market status, past market performance and product details are presented.

Salient Features Of The Report:

The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) report serves as a vital guide in portraying present and forecast industry statistics and market size. The supply/ demand situation, gross margin view and competitive profile of top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) players are presented. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market breakdown by product, type, application and regions will provide sophisticated and precise analysis. Recent developments in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry, growth opportunities, constraints are studied completely. Also, new product launch events, mergers & acquisitions of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), and industry plans and policies are covered.

The revenue estimates of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market based on top industry players, their product type, applications and regions is studied. The cost structures, gross margin view, sales channel analysis and value chain is explained. In the next segment, the SWOT analysis of players, cost structures, traders, distributors and dealers are listed. The forecast study on Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry will be useful for business plans and growth analysis.

To know More Details About Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market research Report @:

https://www.globalmarketers.biz/report/life-sciences/2014-2029-report-on-global-circulating-tumor-cells-(ctcs)-and-cancer-stem-cells-(cscs)-market-by-player,-region,-type,-application-and-sales-channel/152503#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

Follow this link:
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview With Detailed Analysis, Competitive Landscape, Emerging Trends ,...

Posted in Stem Cells | Comments Off on Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview With Detailed Analysis, Competitive Landscape, Emerging Trends ,…

Page 841«..1020..840841842843..850860..»